CIT-Logo-White Created with Sketch.
News Issue Archive Device Guide Calendar Subscribe Advertising

MENU

Device Guides
Trial Guide
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions
Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

Advertisement

Advertisement

Search Results

Show Filters

close Created with Sketch.

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Advertisement

Sort By:

Relevance Date

Choose Sites to Search:

CIToday CIToday + EVToday

cit | Article | July/August 2008

MRI for Plaque Assessment

An overview of the literature.

By Federico E. Mordini, MD; Steven Smart, MD; and Ioannis Koktzoglou, PhD

cit | Article | July/August 2008

Lesion Assessment

By Ted E. Feldman, MD, FSCAI, Chief Medical Editor

cit | News | March 12, 2025

Medtronic’s Evolut TAVR Studied for Patients with Small Annuli in SMART

March 12, 2025—Medtronic recently announced 2-year results from the SMART trial of transfemoral transcatheter aortic valve replacement (TAVR) in patients with symptomatic severe aortic stenosis and a small aortic annulus.

cit | News | June 7, 2024

Medtronic CoreValve/Evolut TAVR Systems’ Performance Evaluated in Updated Analyses

June 7, 2024—Medtronic announced new data from the CoreValve Evolut clinical program, evaluating the performance of the company’s Evolut transcatheter aortic valve replacement (TAVR) system compared to surgical aortic valve replacement (SAVR) and other TAVR devices.

Advertisement

Advertisement

cit | Article | October/November 2008

Society for Cardiac Angiography and Interventions

Steven R. Bailey, MD, FACC, FSCAI, President-elect (2009–2010) of the SCAI, discusses the results of SYNTAX and HORIZONS AMI, the society's plans for 2009, and his thoughts on future studies.

By Steven R. Bailey, MD, FACC, FSCAI,

cit | Article | January/February 2014

The Sunshine Act Inevitably Rises

2014's key implementation dates and how physicians can be better prepared for them.

By Steven J. Cagnetta, Esq., and Steven K. Ladd

cit | Article | January/February 2018

Ask the Experts: What Is the Role of Mitral Repair in Heart Failure?

Experts discuss treatment strategies for patients with mitral regurgitation progressing to heart failure.

With William Weir, MD; Steven F. Bolling, MD; Brian Whisenant, MD; Nyal Borges, MD; Samir Kapadia, MD, FACC, FSCAI; Muath Bishawi, MD; and Donald D. Glower Jr, MD

cit | News | March 30, 2014

Shimadzu Receives FDA Clearance for Trinias Digital Angiography Systems

March 26, 2014—Shimadzu Medical Systems USA (Torrance, CA) announced the US Food and Drug Administration 510(k) clearance for the company’s ceiling-mounted Trinias, floor-mounted Trinias, and Trinias Biplane digital angiography systems.  According to the company, Shimadzu’s ultra-high speed Score Pro image-processing technology aids workflow efficiency.

cit | Article | July/August 2014

Transcatheter Heart Valve Landscape

By Ted E. Feldman, MD, MSCAI, FACC, FESC

cit | Article | September/October 2022

Contemporary Mitral & Tricuspid Therapies

By Gagan D. Singh, MD, and Azeem Latib, MD

cit | News | July 1, 2020

Findings Published From Initial United States Experience With Abiomed Impella 5.5 With SmartAssist

July 1, 2020—Abiomed announced the publication of findings from the initial United States commercial experience with the company’s Impella 5.5 heart pump with SmartAssist.

cit | Article | May/June 2014

Radial Versus Femoral: Choosing the Best Option for Each Patient

Experts Sunil Rao, MD, and Timothy Sanborn, MD, discuss their opinions on access, pharmacology, patient selection, and the use of closure devices.

cit | News | May 7, 2015

OUTSIDE START Shows Effectiveness of Bridge Therapy Using Cilostazol

May 8, 2015—The Society for Cardiovascular Angiography and Interventions (SCAI) announced findings from the OUTSIDE START study demonstrating that patients who received a paclitaxel-eluting stent (PES) that carried a higher stent thrombosis risk and were given the shorter-acting antiplatelet drug cilostazol before a surgical procedure safely transitioned off of dual-antiplatelet therapy (DAPT) to reduce the risk of bleeding during the procedure.  Principal Investigator Charles Laham, MD, presented “OUTSIDE START Cilostazol Bridging Study: 8-Year Experience With Outpatient Cilostazol Bridging in High Stent Thrombosis Risk Paclitaxel Drug-Eluting Stents in Patients Having Surgery During the Proven At-Risk Period” as a late-breaking clinical trial at the SCAI 2015 scientific sessions being held May 6–9 in San Diego, California.

cit | Article | September/October 2012

Understanding Medication Adherence

Implications for dual-antiplatelet therapy.

By Marie T. Brown, MD, FACP, and Ted E. Feldman, MD, FESC, FACC, FSCAI

cit | Article | 2025 Digital Exclusive No. 3

Pearls and Pitfalls to a Hub-and-Spoke Model for Cardiogenic Shock

Leaders in shock care offer insights into the use of a hub-and-spoke model to treat time-sensitive cases.

With Saraschandra Vallabhajosyula, MD, MSc; Shubhadarshini Pawar, MBBS, MPH; Behnam N. Tehrani, MD; Lindsey Cilia, MD; Alexander G. Truesdell, MD; Gerin R. Stevens, MD, PhD, FACC, FHFSA; and Robert O. Roswell, MD, FACC, FACP

cit | Article | June 2007

Percutaneous Aortic Valve Replacement

An overview of catheter-based applications.

By Jacob Green, MD; Vasilis Babaliaros, MD; and Peter Block, MD

cit | Article | September/October 2011

The CoreValve Program

Cardiac Interventions Today interviews Carlos E. Ruiz, MD, PhD, who shares his expertise on the current status of the CoreValve device and trial data.

cit | Article | March/April 2023

Structural Heart Programming: Evolving to Meet the Demand

Standardizing programs, reducing overlicensure, and tracking referral/throughput measures are key to optimizing structural heart care delivery.

By Ginger Biesbrock, DSC, PA-C, FACC

cit | Article | July/August 2010

TAVI Using the CoreValve Revalving System

An update on device data and the latest trial findings.

By Jeffery J. Popma, MD; Roger Laham, MD; Robert Hagberg, MD; and Kamal Khabbaz, MD

Sponsored by Edwards Lifesciences

cit | Article | May/June 2023

Optimized Patient Care Pathway

A discussion with Andrei Pop, MD, at TCT 2022 on refining a minimalistic TAVR program.


1
2

Advertisement

Advertisement

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions
Centers

Coding CTO DES Hypertension Imaging Modalities PCI Pharmacology Radial Regulatory Structural Disease Valvular Interventions

News• Current Issue• Archive• Device Guides• Advertising• About Calendar• Contact• Privacy• Submissions• Subscriptions


Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions.



magazine Created with Sketch.

Free Print Subscriptions

Fill 1 Created with Sketch.

Email Newsletter



twitter-icon LinkedIn Created with Sketch. BlueSky-Circle
Endovascular Today
CIT-Logo-Color Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button